Rhumbline Advisers Relay Therapeutics, Inc. Transaction History
Rhumbline Advisers
- $105 Billion
- Q2 2024
A detailed history of Rhumbline Advisers transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 163,895 shares of RLAY stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
163,895
Previous 156,387
4.8%
Holding current value
$1.06 Million
Previous $1.3 Million
17.72%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding RLAY
# of Institutions
183Shares Held
127MCall Options Held
1.7KPut Options Held
18K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$181 Million1.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$76 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$68.4 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY8.45MShares$54.8 Million4.77% of portfolio
-
Bellevue Group Ag Kuesnacht, V86.38MShares$41.4 Million0.7% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $780M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...